CareLit · DOI-Nachweis · Klinische Pädiatrie
Uncovering the role of lysyl oxidase-like 2 (LOXL2) in rhabdomyosarcoma
DOI 10.1055/s-0036-1582505
Bibliografische Angaben
Nachweis in CareLit
Autor:innenO Almacellas-Rabaiget, J Huertas-Martínez, S García-Monclús, S Rello-Varona, D Herrero-Martín, R López-Alemany, OM Tirado
ZeitschriftKlinische Pädiatrie
Ausgabe05/2016
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Introduction: Rhabdomyosarcoma (RMS) is the most common soft tissue malignancy in childhood and adolescence that originates as a consequence of regulatory disruption in the growth and differentiation of muscle precursor cells. Previous results of our group deciphered the epigenetic profiling of RMS, compared to healthy tissue, revealing the hypomethylation of a potential enhancer of LOXL2. LOXL2 is an amine oxidase…
Zitieren
Zitierempfehlung
O Almacellas-Rabaiget, J Huertas-Martínez, S García-Monclús, S Rello-Varona, D Herrero-Martín, R López-Alemany, OM Tirado (2016) Uncovering the role of lysyl oxidase-like 2 (LOXL2) in rhabdomyosarcoma. Klinische Pädiatrie (05). https://doi.org/10.1055/s-0036-1582505
Mit CareLit weiterarbeiten